Gambro receives slap on wrist after FDA inspection of Italian facility
This article was originally published in Clinica
Executive Summary
The FDA has blocked three of Gambro's haemodialysis monitoring products from entering the US in response to "concerns" brought about during an inspection of the Italian facility where the machines are manufactured.